SCHEMBL650207

SCHEMBL650207

N#Cc1cccc(S(=O)(=O)NC2Cc3cc(Cl)ccc3N(Cc3ccccc3)C2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 7/20 0.61
FNTB P49356 7/20 0.61
THRB P10828 1/20 0.45
CCR1 P32246 1/20 0.43
CCR2 P41597 1/20 0.43
CCR4 P51679 1/20 0.43
HTT P42858 1/20 0.41
NR1H2 P55055 1/20 0.41
HTR1A P08908 2/20 0.40
HTR7 P34969 2/20 0.40
F10 P00742 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
HRH2 P25021 1/20 0.39
HRH1 P35367 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651578 0.95 FNTA (0.62) FNTAFNTBTHRBCCR1CCR2
SCHEMBL650167 0.90 FNTA (0.67) FNTAFNTBTHRBHTT
SCHEMBL650165 0.90 FNTA (0.67) FNTAFNTBTHRBHTT
SCHEMBL651191 0.90 FNTA (0.67) FNTAFNTBTHRBHTT
SCHEMBL650799 0.89 FNTA (0.61) FNTAFNTBTHRBHTR1AHTR7
SCHEMBL651936 0.89 FNTA (0.61) FNTAFNTBTHRBHTR1AHTR7
SCHEMBL651452 0.89 FNTA (0.67) FNTAFNTBTHRBHTTNR1H2
SCHEMBL651451 0.89 FNTA (0.67) FNTAFNTBTHRBHTTNR1H2
SCHEMBL653554 0.89 FNTA (0.71) FNTAFNTBTHRBNR1H2MTNR1A
SCHEMBL648851 0.89 FNTA (0.71) FNTAFNTBTHRBNR1H2MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884113-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-08 US claimed
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2008-08-14 US claimed
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2005-01-20 US claimed
US-8119808-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-21 US disclosed
US-20110104315-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2011-05-05 US disclosed
US-7884113-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-08 US disclosed
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2008-08-14 US disclosed
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110104315-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885THRB 809/4885
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885THRB 809/4885
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885THRB 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.